Papadimitropoulou, A.; Vellon, L.; Atlas, E.; Steen, T.V.; Cuyà s, E.; Verdura, S.; Espinoza, I.; Menendez, J.A.; Lupu, R.
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 7737.
https://doi.org/10.3390/ijms21207737
AMA Style
Papadimitropoulou A, Vellon L, Atlas E, Steen TV, Cuyàs E, Verdura S, Espinoza I, Menendez JA, Lupu R.
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer. International Journal of Molecular Sciences. 2020; 21(20):7737.
https://doi.org/10.3390/ijms21207737
Chicago/Turabian Style
Papadimitropoulou, Adriana, Luciano Vellon, Ella Atlas, Travis Vander Steen, Elisabet Cuyà s, Sara Verdura, Ingrid Espinoza, Javier A. Menendez, and Ruth Lupu.
2020. "Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer" International Journal of Molecular Sciences 21, no. 20: 7737.
https://doi.org/10.3390/ijms21207737
APA Style
Papadimitropoulou, A., Vellon, L., Atlas, E., Steen, T. V., Cuyà s, E., Verdura, S., Espinoza, I., Menendez, J. A., & Lupu, R.
(2020). Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer. International Journal of Molecular Sciences, 21(20), 7737.
https://doi.org/10.3390/ijms21207737